PNC Financial Services Group
LXRX icon

PNC Financial Services Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

PNC Financial Services Group’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51K Hold
1,461
– – ﹤0.01% 4514
2026
Q1 		$2.28K Hold
1,461
– – ﹤0.01% 4538
2025
Q4 		$1.68K Hold
1,461
– – ﹤0.01% 4570
2025
Q3 		$1.97K Hold
1,461
– – ﹤0.01% 4503
2025
Q2 		$1.38K Hold
1,461
– – ﹤0.01% 4505
2025
Q1 		$673 Buy
1,461
+1,350
+1,216% +$852 ﹤0.01% 4579
2024
Q4 		$82 Hold
111
– – ﹤0.01% 4717
2024
Q3 		$174 Hold
111
– – ﹤0.01% 4692
2024
Q2 		$186 Hold
111
– – ﹤0.01% 4676
2024
Q1 		$266 Hold
111
– – ﹤0.01% 4577
2023
Q4 		$170 Buy
+111
New +$132 ﹤0.01% 4497
2019
Q4 		– Sell
-34
Closed – – 4054
2019
Q3 		$0 Hold
34
– – ﹤0.01% 4064
2019
Q2 		$0 Hold
34
– – ﹤0.01% 4085
2019
Q1 		$0 Hold
34
– – ﹤0.01% 4086
2018
Q4 		$0 Sell
34
-4,428
-99% -$35.9K ﹤0.01% 4117
2018
Q3 		$48K Buy
4,462
+340
+8% +$3.9K ﹤0.01% 3021
2018
Q2 		$49K Buy
4,122
+4,067
+7,395% +$41.6K ﹤0.01% 2987
2018
Q1 		$0 Sell
55
-13
-19% -$120 ﹤0.01% 4237
2017
Q4 		$0 Buy
68
+29
+74% +$301 ﹤0.01% 4200
2017
Q3 		$0 Sell
39
-136
-78% -$2.01K ﹤0.01% 4190
2017
Q2 		$3K Buy
+175
New +$2.71K ﹤0.01% 3926
2016
Q3 		– Sell
-243
Closed -$3K – 4144
2016
Q2 		$3K Sell
243
-9
-4% -$122 ﹤0.01% 4039
2016
Q1 		$3K Buy
252
+9
+4% +$94 ﹤0.01% 4049
2015
Q4 		$3K Hold
243
– – ﹤0.01% 4044
2015
Q3 		$3K Buy
243
+8
+3% +$87 ﹤0.01% 4153
2015
Q2 		$2K Buy
235
+106
+82% +$779 ﹤0.01% 4405
2015
Q1 		$1K Hold
129
– – ﹤0.01% 4492
2014
Q4 		$1K Hold
129
– – ﹤0.01% 3996
2014
Q3 		$1K Hold
129
– – ﹤0.01% 3839
2014
Q2 		$1K Hold
129
– – ﹤0.01% 3691
2014
Q1 		$2K Buy
+129
New +$1.65K ﹤0.01% 3488

Other funds holding LXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

PNC Financial Services Group's LXRX Position: Q2 2026 in Review

PNC Financial Services Group held its Lexicon Pharmaceuticals (LXRX) position steady in Q2 2026 at 1,461 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

PNC Financial Services Group first reported a position in LXRX in Q1 2014 and has held it in 31 quarters since. The position peaked at $49K in Q2 2018. 51 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • PNC Financial Services Group held 1,461 shares of Lexicon Pharmaceuticals worth $3.51K as of Q2 2026.
  • PNC Financial Services Group left its Lexicon Pharmaceuticals share count unchanged in Q2 2026.
  • Lexicon Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4514 holding.
  • PNC Financial Services Group first reported a position in Lexicon Pharmaceuticals in Q1 2014 and has held it in 31 quarters since.
  • PNC Financial Services Group's Lexicon Pharmaceuticals position peaked at $49K in Q2 2018.
  • 51 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.